ArticleBMC genomic data2026
Draft genome of novel Streptomyces sp. strain JW3 selected for its inhibition of other Streptomyces spp.
Article in BMC genomic data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
objectivesDespite decades of extensive investigation, Streptomyces species continue to represent a vast and rich reservoir of novel bioactive compounds. Accordingly, genome mining remains a powerful and strategic approach for the discovery of new candidate drugs. The objective of the present study is to generate a high-quality, assembled, and functionally annotated draft genome of a novel Streptomyces species, providing a robust genomic framework for downstream comparative and biosynthetic analyses. DATA DESCRIPTION: Here, we report the first assembled and annotated draft genome of the novel soil-derived Streptomyces sp. strain JW3. High-throughput sequencing of Streptomyces sp. strain JW3 genome generated approximately 1.6 million reads, corresponding to a total of 465.4 million bases and an effective sequencing yield of 157.3 Mb. De novo assembly produced a draft genome of 8.3 Mb distributed across 341 contigs, with an N
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.